Company: MDCXW
Filing Date: 2025-05-27
Form Type: S-1
Source: 0001062993-25-010394
Chunk: 166

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-27
Form: S-1
Chunk 166
---
                                              |     |       58,122 |  -8 |     |             * |   |
| Larry Kaiser                                               |     |       32,500 |  -9 |     |             * |   |
| Barry Fishman                                              |     |       32,500 | -10 |     |             * |   |
| Sara R. May                                                |     |       32,500 | -11 |     |             * |   |
| All officers and directors as a group (11 individuals)     |     |    1,872,597 |     |     |          13.0 | % |
| Five Percent Holders of Medicus Pharma Ltd.                |     |              |     |     |               |   |
| Dr. Kenneth Melani                                         |     |    3,248,741 | -12 |     |          23.9 | % |
| Ajay Raju                                                  |     |    2,000,000 | -13 |     |          14.7 | % |
| Steven Boyd                                                |     |    1,266,000 | -14 |     |           9.3 | % |
| John Hathaway                                              |     |      800,952 | -15 |     |           5.9 | % |

* Less than one percent.

(1)Unless otherwise noted, the business address of each of our directors and executive officers is 300 Conshohocken State Rd., Suite 200, W. Conshohocken, PA 19428.

(2)Includes 793,173 common shares held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. Dr. Raza Bokhari may be deemed the beneficial owner of securities held by RBx Capital, LP. Includes 275,000 common shares underlying stock options that are currently exercisable.

<div align='center'>115</div>

(3)Includes 135,000 common shares underlying stock options and 24,000 common shares underlying Public Warrants that are currently exercisable or will become exercisable.

(4)Includes 67,500 common shares underlying stock options that are currently exercisable.

(5)Includes 85,000 common shares underlying stock options and 24,000 common shares underlying Public Warrants that are currently exercisable.

(6)Includes 32,500 common shares underlying stock options that are currently exercisable.

(7)Includes 32,500